Dose Range Study to Evaluate the Efficacy and Safety of AV5080 in Patients With Influenza

NCT05095545 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
135
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Viriom